Session 1: Presentations

Chair: Prof Dorian Haskard

14:00 Dr Joseph J Boyle: General introduction

14:05 Blerina Ahmataj-Sala Vascular: Network News

14:10 Peter Openshaw: “Perspectives on COVID-19”

14:20 Ramzi Khamis: “The clinical syndrome of COVID vascular disease”

14:30 Nicola Cooper: “Hypercoagulability in COVID”

14:40 Blerina Ahmetaj-Shala: “Vessel transcriptomics and COVID”

14:50 Joseph J Boyle: “Long term impact of COVID”

15:00 Anna Randi; Title TBC.

15:10-15:30 Break

Session 2: Panel discussion (15:30-16:30)

Moderators: Joseph J Boyle, Beata Wojciak-Stothard

Questions by chat function in Microsoft Teams. Please upvote interesting questions using the ‘like’ (thumbs-up icon). Please also discuss items in Chat. Moderators will select highly upvoted questions, items of discussion, further interesting questions that they select from chat function. Panel can also ask questions.

Panel: Peter Openshaw, Anna Randi, Nichola Cooper, Ramzi Khamis, Blerina Ahmetaj-Shala, tbc.

A further 4 key questions suggested in advance have been:
1 Need vascular research change ?
2. What changes should we anticipate ? And what changes should we use this as an opportunity to effect ?
3. How may COVID be leveraged to support vascular research ?
4. What could COVID syndromes tell us about basic vascular physiology and pathophysiology ?